Chemed Corp. (NASDAQ:CHE) — is a diversified health care facilities company that operates through two subsidiaries, VITAS Healthcare and Roto-Rooter Group. Although it beat Q3 estimates by 9.09%, the stock has not been able to break from its long-term bear market.
And last week, two law firms announced that an investigation into alleged Medicare and Medicaid fraud amounting to millions of dollars was filed against the company. Technically the stock broke down from a consolidation at $52, and a weak rebound failed to close above its 50-day moving average — a negative sign.
Note that the stochastic’s fast line (red) issued a new sell signal and, thus, the low at $48.10 will probably be broken. The downside target for short sellers and buyers of put options is $43.